Skip to content

Prime PCA and PCA/Continuous Systems

by Prime Medical Products, Inc.

510(k) K920637

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK920637 Date15 Jan 1993ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
MEA
Device Class
Class II
Regulation
21 CFR Part 880.5725
Advisory Committee
General Hospital
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Prime PCA and PCA/Continuous Systems are patient-controlled analgesia (PCA) infusion pumps designed for delivering continuous or on-demand intravenous analgesia. These devices facilitate precise dosing of pain medications, enabling patients to self-administer prescribed doses while healthcare providers maintain control over basal infusion rates and safety limits.

Intended for use in general hospital settings, these systems are classified as Class II medical devices under FDA regulations (880.5725) and have received a 510(k) clearance (K920637). The devices are reusable and require proper sterilization and maintenance as per manufacturer guidelines. No specific MRI safety information is provided, and their operation adheres to standard infusion pump protocols for patient safety and compliance.

Other devices from Prime Medical Products, Inc.

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • Are these PCA pumps designed for single-use or can they be reused in a clinical setting?

    The Prime PCA and PCA/Continuous Systems are reusable devices. They require proper sterilization and maintenance as outlined by the manufacturer to ensure safe, repeated use in hospital settings. This design aligns with standard practices for infusion pumps in general hospital environments.

  • What types of pain management scenarios are these pumps intended for, and how do they differ from standard infusion pumps?

    These pumps are specifically designed for patient-controlled analgesia (PCA), allowing patients to self-administer prescribed doses of pain medication while healthcare providers set basal infusion rates and safety limits. Unlike standard infusion pumps, they combine on-demand dosing (via patient activation) with continuous infusion capabilities, providing flexibility for acute pain management in general hospital settings.

  • How many different models or variations of these PCA pumps exist, and are they all compatible with each other?

    The Prime PCA and PCA/Continuous Systems include multiple models, as indicated by the listed FEI numbers (e.g., 3010381606, 3002999813, etc.). While the exact specifications of each model aren’t detailed here, they are all classified under the same product code (MEA) and intended for general hospital use. Compatibility should be verified with the manufacturer, as variations may exist in functionality or connectivity.

  • What storage or handling requirements should be followed for these reusable PCA pumps before and after use?

    Since these pumps are reusable, they must be properly sterilized and maintained between uses to prevent contamination and ensure reliability. The manufacturer provides guidelines for sterilization and care, which should be strictly followed. Storage should occur in a clean, dry environment away from direct sunlight or extreme temperatures to preserve functionality and safety.

  • How were these pumps evaluated for safety and equivalence to prior devices, and what regulatory pathway was followed?

    The Prime PCA and PCA/Continuous Systems were cleared through the FDA’s 510(k) process, with a decision dated January 15, 1993, under the Traditional pathway. The submission was classified as Substantially Equivalent (SESE) to prior devices and falls under product code MEA, intended for general hospital use. The review was conducted by the Hospital/Orthopedic (HO) Advisory Committee, ensuring compliance with infusion pump safety standards.